Target intelligence / Profile preview

Small Blood Vessels

Molecular classification
Other (not a receptor, enzyme, transporter, etc.)
01

Overview

Small blood vessels are components of the vasculature consisting mainly of capillaries, which are composed of an endothelial cell monolayer and a basal lamina, sometimes surrounded by pericytes. Arterioles and venules, while slightly larger, are often grouped with capillaries as microvessels for pathological or pharmacological discussion. Capillaries are involved in gas and nutrient exchange, waste removal, and play critical roles in inflammation, angiogenesis, and wound healing. Structural types include continuous, fenestrated, and sinusoidal capillaries, each adapted to specific tissue and organ needs. In disease, microvasculature is central to pathologies such as diabetes, cancer (where microvessel density is a biomarker), and cardiovascular disease. While drugs can target cells within small blood vessels (such as antiangiogenics targeting endothelial cell proliferation in tumors), "small blood vessels" themselves are not a molecular or single receptor target and thus cannot be classified as a canonical "target" for therapy[2][3][5][1]. Key clarifications: - "Small blood vessels" is not a canonical molecule or receptor, nor a singular protein/gene product; it describes a structural class of tissues made up of various cell types (endothelial cells, pericytes, basement membrane). - All subsequent molecular, drug, biomarker or disease roles relate primarily to features or pathophysiology of these vessels rather than to "small blood vessels" as a single molecular target. For future structuring, consider using "Capillary" or specifying cell or molecular targets (e.g., "Endothelial cell (of capillary blood vessel)", "VEGF receptor", etc.) if a true molecular target is intended.

Other names
Small vesselMicrovesselCapillaryMicrovasculatureMicrovascular vessel
02

Biological functions

Tissue perfusionGas exchange (O2, CO2)Nutrient deliveryWaste removalInflammationAngiogenesis
03

Disease associations

Cardiovascular disease (e.g., microangiopathy in diabetes, hypertension)InflammationCancer (tumor angiogenesis, microvessel density as a marker)Neurodegenerative disease (microvascular compromise)Diabetic complications (retinopathy, nephropathy)Other (ischemia, vasculitis, infection)
04

Safety considerations

Off-target effects when targeting vasculature (e.g., bleeding, impaired healing)Impaired angiogenesis leading to ischemiaVascular leakage, edema, thrombosis
05

Biomarkers

Microvessel densityCD31 (endothelial marker)CD34Ki67 (proliferation marker in vessels in cancer context)Ephrin-B2/EphB4 (vessel identity markers)

Beyond the preview

Go deeper on Small Blood Vessels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Blood Vessels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call